In a recent study, researchers examined the efficacy and impact of various direct oral anticoagulants on multiple health outcomes in individuals with atrial fibrillation.
Because the safety of individual DOACs relative to warfarin for specific bleeding outcomes in patients with atrial fibrillation is unclear, the researchers compared the safety of 3 DOACs with the safety of...
Despite a lack of clear therapeutic indication, many patients receiving anticoagulation therapy with warfarin are also treated with aspirin. In a recent study, researchers sought to evaluate the frequency...
Although previous observation data has suggested that certain non-vitamin K oral anticoagulants convey different risks of gastrointestinal bleeding, the clinical importance of anticoagulant choice, and how...
At CHEST 2018, researchers presented research that can help determine whether direct oral anticoagulants are safe and effective when compared with warfarin.
To evaluate the effect of anticoagulation therapy on the risks for bleeding and all-cause mortality, the researchers assessed nearly 200,000 patients with and without atrial fibrillation who initiated...
In an analysis of nearly 32,000 patients with atrial fibrillation, researchers examined the effects of direct oral anticoagulants vs vitamin K antagonists on the risk for myocardial infarction.
In order to improve patient care, the American College of Cardiology has released guidance on the management of bleeding events among patients receiving anticoagulation therapy.
While the association between atrial fibrillation and dementia is well known, the protective effects of oral anticoagulant treatment in these patients has not been well studied.
